Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Dave Inman, MSc

GlaxoSmithKline, United Kingdom

Disclosure(s): GlaxoSmithKline: Employee, Stocks/Bonds

Poster(s):

1150 - Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET